Neurofibromatoses: Clinical Trials

2 trials for Neurofibromatoses, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 2

Follow Neurofibromatoses: new trials by email Literature Review of Neurofibromatoses trials Research Report on Neurofibromatoses

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dexmedetomidine and Propofol for Pediatric MRI Sedation
propofol, Dexmedetomidine, Glycopyrrolate - Headache, Tumor
Phase 4CompletedMedical College of Wisconsin402018-03-042020-02-21
NF1-Attention: Study of Children With Neurofibromatosis Type 1 Treated by Methylphenidate
methylphenidate - Neurofibromatosis Type 1
Phase 4CompletedHospices Civils de Lyon802004-01-012011-01-27

Narrower conditions

Abdominal Neoplasms (1)  ·  Epilepsy (1)  ·  Headache (1)  ·  Hydrocephalus (1)  ·  Neoplasms (1)  ·  Neurofibromatosis 1 (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Genetic Diseases, Inborn (2)  ·  Heredodegenerative Disorders, Nervous System (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms, Nerve Tissue (2)  ·  Neoplastic Syndromes, Hereditary (2)  ·  Nerve Sheath Neoplasms (2)  ·  Nervous System Diseases (2)  ·  Neurocutaneous Syndromes (2)  ·  Neurodegenerative Diseases (2)  ·  Neurofibroma (2)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)

Interventions

Dexmedetomidine (1)  ·  Glycopyrrolate (1)  ·  Lidocaine (1)  ·  Methylphenidate (1)  ·  Nitrous Oxide (1)  ·  Propofol (1)  ·  Sevoflurane (1)

Sponsors

Hospices Civils de Lyon (1)  ·  Medical College of Wisconsin (1)

Countries

France (1)  ·  United States (1)

Top investigators

Susan P Taylor, MD, MPH (1)

Results publications

PMID 25205361